Migraine and childhood periodic syndromes in children and adolescents

Current Opinion in Neurology

Volumn 26, Issue 3, 2013, Pages 262-268

  Gelfand, Amy A ^a,b  

^a Divisions of Child Neurology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

abdominal migraine; childhood periodic syndromes; cyclic vomiting syndrome; pediatric headache; pediatric migraine

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; BOTULINUM TOXIN A; DIHYDROERGOTAMINE; FLUNARIZINE; KETOROLAC; NAPROXEN; NOSE SPRAY; PROCHLORPERAZINE; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; VALPROATE SEMISODIUM; ZOLMITRIPTAN;

AKATHISIA; ANALGESIA; AVOIDANCE BEHAVIOR; BENIGN PAROXYSMAL VERTIGO OF CHILDHOOD; CHILD HEALTH CARE; CLINICAL FEATURE; COHORT ANALYSIS; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; FATTY ACID OXIDATION; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; INCIDENCE; INFANCY; MEDICAL RESEARCH; MIGRAINE; ONSET AGE; PRACTICE GUIDELINE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SHAKEN BABY SYNDROME; SIDE EFFECT; STRESS; TORTICOLLIS; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIGRAINE DISORDERS; TORTICOLLIS; TRYPTAMINES; VERTIGO; VOMITING;

EID: 84877700268     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32836085c7     Document Type: Review

References (91)

1. Lewis DW. Pediatric migraine. Pediatr Rev 2007; 28:43-53. (Pubitemid 46495844)
2. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl 1):9-160.
3. Senbil N, Gurer YK, Uner C, Barut Y. Sinusitis in children and adolescents with chronic or recurrent headache: a case-control study. J Headache Pain 2008; 9:33-36.
4. Gupta R, Bhatia MS. A report of cranial autonomic symptoms in migraineurs. Cephalalgia 2007; 27:22-28. (Pubitemid 46020797)
5. Barbanti P, Fabbrini G, Pesare M, et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia 2002; 22:256-259. (Pubitemid 41701441)
6. Obermann M, Yoon MS, Dommes P, et al. Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia 2007; 27:504-509. (Pubitemid 46848914)
7. Aromaa M, Sillanpaa ML, Rautava P, Helenius H. Childhood headache at school entry: a controlled clinical study. Neurology 1998; 50:1729-1736. (Pubitemid 28283242)
8. Fuh JL, Wang SJ, Lu SR, et al. Headache disability among adolescents: a student population-based study. Headache 2010; 50:210-218.
9. Arruda MA, Bigal ME. Migraine and migraine subtypes in preadolescent children: Association with school performance. Neurology 2012; 79:1881-1888.
10. Lipton RB, Manack A, Ricci JA, et al. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache 2011; 51:693-706.
11. Rosman NP, Douglass LM, Sharif UM, Paolini J. The neurology of benign paroxysmal torticollis of infancy: report of 10 new cases and review of the literature. J Child Neurol 2009; 24:155-160.
12. Krams B, Echenne B, Leydet J, et al. Benign paroxysmal vertigo of childhood: long-term outcome. Cephalalgia 2011; 31:439-443.
13. Gelfand AA, Thomas KC, Goadsby PJ. Before the headache: Infant colic as an early life expression of migraine. Neurology 2012; 79:1392-1396.
14. Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol 2002; 44:490-493. (Pubitemid 34808757)
15. Cuenca-Leon E, Corominas R, Fernandez-Castillo N, et al. Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes. Cephalalgia 2008; 28:1039-1047.
16. Castro-Rodriguez JA, Stern DA, Halonen M, et al. Relation between infantile colic and asthma/atopy: a prospective study in an unselected population. Pediatrics 2001; 108:878-882. (Pubitemid 32947656)
17. Lucassen PL, Assendelft WJ, van Eijk JT, et al. Systematic review of the occurrence of infantile colic in the community. Arch Dis Child 2001; 84:398-403. (Pubitemid 32411228)
18. Bruni O, Fabrizi P, Ottaviano S, et al. Prevalence of sleep disorders in childhood and adolescence with headache: a case-control study. Cephalalgia 1997; 17:492-498. (Pubitemid 27248484)
19. Jan MM, Al-Buhairi AR. Is infantile colic a migraine-related phenomenon? Clin Pediatr (Phila) 2001; 40:295-297. (Pubitemid 32466526)
20. Barr RG, Trent RB, Cross J. Age-related incidence curve of hospitalized Shaken Baby Syndrome cases: convergent evidence for crying as a trigger to shaking. Child Abuse Negl 2006; 30:7-16. (Pubitemid 43143393)
21. Brazelton TB. Crying in infancy. Pediatrics 1962; 29:579-588.
22. Roubertie A, Echenne B, Leydet J, et al. Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family. J Neurol 2008; 255:1600-1602.
23. Dale RC, Gardiner A, Antony J, Houlden H. Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol 2012; 54:958-960.
24. Lee LY, Abbott L, Mahlangu B, et al. The management of cyclic vomiting syndrome: a systematic review. Eur J Gastroenterol Hepatol 2012; 24:1001-1006.
25. Kumar N, Bashar Q, Reddy N, et al. Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms-pediatric versus adult? BMC Gastroenterol 2012; 12:52.
26. Fitzgerald M, Crushell E, Hickey C. Cyclic vomiting syndrome masking a fatal metabolic disease. Eur J Pediatr 2012 [Epub ahead of print].
27. Hikita T, Kodama H, Kaneko S, et al. Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial. Cephalalgia 2011; 31:504-507.
28. Boles RG. High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series. BMC Neurol 2011; 11:102.
29. Kothare SV. Efficacy of flunarizine in the prophylaxis of cyclical vomiting syndrome and abdominal migraine. Eur J Paediatr Neurol 2005; 9:23-26. (Pubitemid 40214767)
30. Carson L, Lewis D, Tsou M, et al. Abdominal migraine: an under-diagnosed cause of recurrent abdominal pain in children. Headache 2011; 51:707-712.
31. Kakisaka Y, Wakusawa K, Haginoya K, et al. Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders: does the mechanism overlap that of migraine? J Child Neurol 2010; 25:234-237.
32. Linder SL, Mathew NT, Cady RK, et al. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2008; 48:1326-1336.
33. Ahonen K, Hamalainen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology 2006; 67:1135-1140. (Pubitemid 44563817)
34. Lewis DW, Winner P, Hershey AD, Wasiewski WW. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007; 120:390-396. (Pubitemid 47219510)
35. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999; 52:1507-1510. (Pubitemid 29190554)
36. Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial. Neurology 2004; 62:883-887. (Pubitemid 38435772)
37. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebocontrolled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000; 106:989-997.
38. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007; 297:1443-1454. (Pubitemid 46556470)
39. Derosier FJ, Lewis D, Hershey AD, et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics 2012; 129:e1411-e1420.
40. McDonald SA, Hershey AD, Pearlman E, et al. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache 2011; 51:1374-1387.
41. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986; 26:168-171. (Pubitemid 17199220)
42. Saper JR, Silberstein S. Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache 2006; 46 (Suppl 4):S171-S181. (Pubitemid 44656902)
43. Kabbouche MA, Powers SW, Segers A, et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache 2009; 49:106-109.
44. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 2004; 43:256-262. (Pubitemid 38141471)
45. Vinson DR, Drotts DL. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med 2001; 37:125-131. (Pubitemid 32142957)
46. Trottier ED, Bailey B, Lucas N, Lortie A. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med 2012; 30:456-463.
47. Lewis DW, Kellstein D, Dahl G, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002; 42:780-786. (Pubitemid 35291512)
48. Hamalainen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997; 48:103-107. (Pubitemid 27039526)
49. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:754-762.
50. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48:1157-1168.
51. Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: clinical implications. Headache 2006; 46 (Suppl 4):S202-S211. (Pubitemid 44656905)
52. Crawford MJ, Lehman L, Slater S, et al. Menstrual migraine in adolescents. Headache 2009; 49:341-347.
53. Marcus DA, Bernstein CD, Sullivan EA, Rudy TE. Perimenstrual eletriptan prevents menstrual migraine: an open-label study. Headache 2010; 50:551-562.
54. Savi L, Omboni S, Lisotto C, et al. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. J Headache Pain 2011; 12:609-615.
55. Hershey AD. Perimenstrual headache in adolescence. Curr Pain Headache Rep 2012; 16:474-476.
56. Hershey A, Horn P, Kabbouche M, et al. Genomic expression patterns in menstrual-related migraine in adolescents. Headache 2012; 52:68-79.
57. Blume HK, Brockman LN, Breuner CC. Biofeedback Therapy for Pediatric Headache: Factors Associated With Response. Headache 2012; 52:1377-1386.
58. Slater SK, Kashikar-Zuck SM, Allen JR, et al. Psychiatric comorbidity in pediatric chronic daily headache. Cephalalgia 2012; 32:1116-1122.
59. Jansen SC, van Dusseldorp M, Bottema KC, Dubois AE. Intolerance to dietary biogenic amines: a review. Ann Allergy Asthma Immunol 2003; 91:233-240; quiz 241-232, 296.
60. Marcus DA, Scharff L, Turk D, Gourley LM. A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia 1997; 17:855-862; discussion 800. (Pubitemid 28034350)
61. Abu-Salameh I, Plakht Y, Ifergane G. Migraine exacerbation during Ramadan fasting. J Headache Pain 2010; 11:513-517.
62. Drescher MJ, Elstein Y. Prophylactic COX 2 inhibitor: an end to the Yom Kippur headache. Headache 2006; 46:1487-1491. (Pubitemid 44722186)
63. Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol 2010; 9:190-204.
64. Kabbouche M, O'Brien H, Hershey AD. OnabotulinumtoxinA in pediatric chronic daily headache. Curr Neurol Neurosci Rep 2012; 12:114-117.
65. Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol 2007; 22:829-835. (Pubitemid 47261234)
66. Lewis D, Winner P, Saper J, et al. Randomized, double-blind, placebocontrolled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009; 123:924-934.
67. Lewis D, Paradiso E. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study. Headache 2007; 47:1409-1417. (Pubitemid 350209523)
68. Sorge F, De Simone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988; 8:1-6. (Pubitemid 18091138)
69. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000; 40:539-549. (Pubitemid 30497412)
70. Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache 2004; 44:230-237. (Pubitemid 38436685)
71. Apostol G, Lewis DW, Laforet GA, et al. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a standalone, long-term open-label safety study. Headache 2009; 49:45-53.
72. Apostol G, Pakalnis A, Laforet GA, et al. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents. Headache 2009; 49:36-44.
73. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 1974; 50:109-115.
74. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987; 79:593-597. (Pubitemid 17051427)
75. Forsythe WI, Gillies D, Sills MA. Propanolol ('Inderal') in the treatment of childhood migraine. Dev Med Child Neurol 1984; 26:737-741. (Pubitemid 15175452)
76. Diener HC, Hartung E, Chrubasik J, et al. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001; 21:120-128. (Pubitemid 32575475)
77. Schellenberg R, Lichtenthal A, Wohling H, et al. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment? Headache 2008; 48:118-125.
78. Rao BS, Das DG, Taraknath VR, Sarma Y. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India 2000; 48:223-226.
79. O'Brien HL, Kabbouche MA, Hershey AD. Treating pediatric migraine: an expert opinion. Expert Opin Pharmacother 2012; 13:959-966.
80. NINDS (2012). The Childhood and Adolescent Migraine Prevention Study (CHAMP). http://www.ninds.nih.gov/disorders/clinical-trials/NCT01581281. htm [Accessed 18 March 2013].
81. Hershey AD, Powers SW, Vockell AL, et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007; 47:73-80. (Pubitemid 46096060)
82. Slater SK, Nelson TD, Kabbouche MA, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 2011; 31:897-905.
83. Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache 2005; 45:196-203. (Pubitemid 40393207)
84. Anderson N, Meier T, Borlak J. Toxicogenomics applied to cultures of human hepatocytes enabled an identification of novel petasites hybridus extracts for the treatment of migraine with improved hepatobiliary safety. Toxicol Sci 2009; 112:507-520.
85. Wang F, Van Den Eeden SK, Ackerson LM, et al. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003; 43:601-610. (Pubitemid 36828795)
86. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998; 50:466-470.
87. MacLennan SC, Wade FM, Forrest KM, et al. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol 2008; 23:1300-1304.
88. O'Brien HL, Hershey AD. Vitamins and paediatric migraine: Riboflavin as a preventive medication. Cephalalgia 2010; 30:1417-1418.
89. Bruijn J, Duivenvoorden H, Passchier J, et al. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial. Cephalalgia 2010; 30:1426-1434.
90. Hershey AD, Powers SW, Vockell AL, et al. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 2001; 57:2034-2039. (Pubitemid 33126871)
91. Hershey AD, Powers SW, Vockell AL, et al. Development of a patient-based grading scale for PedMIDAS. Cephalalgia 2004; 24:844-849. (Pubitemid 39319181)